Percutaneous hepatic perfusion Percutaneous hepatic perfusion Percutaneous hepatic perfusion (PHP) is a regionalized, minimally-invasive approach to cancer treatment currently undergoing Phase II and Phase III clinical testing. PHP treats a variety of hepatic tumors by isolating the liver and exposing the organ to high-dose chemotherapy. As demonstrated in clinical trials, patients treated by PHP can tolerate much higher doses of chemotherapeutic agents than those receiving traditional systemic chemotherapy without increased toxicities. Using a system of catheters and filters, PHP isolates the liver from the circulatory system and infuses a chemotherapeutic agent directly to the liver via the hepatic artery. The venous effluent from
Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine availability of organs from a deceased person. Any removed parts of the body must be disposed of respectfully in accordance with the wishes of the individual. In addition, there is to be no financial gain arising from the human body or its parts, however adequate compensation for expenses incurred for a medical procedure is not prohibited. The rules relating to consent laid out in "Chapter II" of the Convention also apply in the context of organ transplantation. In accordance with the European Convention on Human Rights, any individual who has suffered damage should have access to fair compensation ("Article 24").